— Know what they know.
Not Investment Advice

Financial News

Sentiment -36.4 4579 articles 2229 bullish 1216 bearish Full Index →
Advanced Cell-based Therapy Booming the Success for Healthca

Advanced Cell-based Therapy Booming the Success for Healthcare Sector

Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 24, 2026 /PRNewswire/ -- USANewsGroup.com — The FDA has approved more than 40 cell and gene...
📰

Inman, a leading source of real estate news, events, and intelligenceAppoints Tom Bohn as Chief Executive Officer

TALLAHASSEE, Fla., March 24, 2026 /PRNewswire-PRWeb/ -- Inman, a leading source of real estate news, events, and intelligence, announced the...
Wall Street Analysts Predict a 51.12% Upside in OrthoPediatr

Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 51.1% in OrthoPediatrics (KIDS). While the effectiveness of...
Here's Why Inovio (INO) Looks Ripe for Bottom Fishing

Here's Why Inovio (INO) Looks Ripe for Bottom Fishing

Inovio (INO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward...
Wall Street Analysts Predict an 182.79% Upside in Assertio (

Wall Street Analysts Predict an 182.79% Upside in Assertio (ASRT): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 182.8% in Assertio (ASRT). While the effectiveness of this...
Move & Connect geht eine Partnerschaft mit KORE ein, um

Move & Connect geht eine Partnerschaft mit KORE ein, um nahtlose europaweite IoT-Konnektivität für kritische Branchen bereitzustellen

ATLANTA, 24. März 2026 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE: KORE), der globale Hyperscaler im Bereich des Internets der Dinge („IoT") und...
📰

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative,...
📰

Here's Why Illumina (ILMN) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
📰

Fresenius (FMS) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
📰

Why Encompass Health (EHC) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
📰

Zoetis (ZTS) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might

After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC)

Bicycle Therapeutics (BCYC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong...
Brokers Suggest Investing in Johnson & Johnson (JNJ): Read T

Brokers Suggest Investing in Johnson & Johnson (JNJ): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Johnson & Johnson (JNJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street...
Wall Street Bulls Look Optimistic About CVS Health (CVS): Sh

Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts...
Is It Worth Investing in UnitedHealth (UNH) Based on Wall St

Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after...
📰

By Light Awarded Alliant 3 GWAC

By Light continues its decades of Federal support with new five-year base period with a five-year option unlimited GWAC award MCLEAN, Va., March 24,...
📰

CIMG Announces Memorandum of Understanding with Bedrock to Explore Compliant Institutional DeFi, Focused on BTC Liquid Staking

HONG KONG, March 24, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: CIMG), a business group specializing in digital health and...
This Ralph Lauren Analyst Turns Bullish; Here Are Top 5 Upgr

This Ralph Lauren Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
What's Going On With MIRA Pharma Stock Tuesday?

What's Going On With MIRA Pharma Stock Tuesday?

MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) stock is pulling back in premarket trading on Tuesday after surging 21.74% to close sharply higher on Monday,...
Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipa

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder

Adial Pharmaceuticals Inc. (NASDAQ:ADIL) on Tuesday commended members of the U.S. Congress for introducing H.R. 7091, the Expanding Veterans'...
📰

Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial

TORONTO, March 24, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today...
INSM Stock Gains After Arikayce Hits Goal in Label Expansion

INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study

Insmed stock jumps as Arikayce meets key goals in a late-stage study, paving the way for label expansion and a major boost to its potential market.
INSM Stock Gains After Arikayce Hits Goal in Label Expansion

INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study

Insmed stock jumps as Arikayce meets key goals in a late-stage study, paving the way for label expansion and a major boost to its potential market.
INSM Stock Gains After Arikayce Hits Goal in Label Expansion

INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study

Insmed stock jumps as Arikayce meets key goals in a late-stage study, paving the way for label expansion and a major boost to its potential market.
📰

ECGI to acquire RezyFi for $25M

📰

MergeWiFi Partners with Aeris to Deliver Secure, Multi-Carrier Fixed Wireless Access for Enterprise Retail and Distributed Enterprises

MergeWiFi Multi-Carrier Gateway Technology Now Integrates with Aeris IoT Watchtower™ to Close the Cellular Security Blind Spot, Giving...
📰

BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025

Positive interim Phase 1 data for BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor,...
📰

BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025

Positive interim Phase 1 data for BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor,...
Billion-Dollar Opportunity Emerges for RF Sensing Technologi

Billion-Dollar Opportunity Emerges for RF Sensing Technologies in Offshore Exploration

Demand surges as operators prioritize safety, uptime, and data-driven operations NEW YORK, March 24, 2026 /CNW/ -- Market News Updates News...
📰

Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer

The company recently obtained approval for a higher-dose version of Wegovy.
📰

Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer

The company recently obtained approval for a higher-dose version of Wegovy.
How Auna S.A. Is Heading Toward Its Net Leverage Target

How Auna S.A. Is Heading Toward Its Net Leverage Target

AUNA holds leverage at 3.6X but targets sub-3X, backed by rising free cash flow, refinancing moves and improving Mexico performance.
How Auna S.A. Is Heading Toward Its Net Leverage Target

How Auna S.A. Is Heading Toward Its Net Leverage Target

AUNA holds leverage at 3.6X but targets sub-3X, backed by rising free cash flow, refinancing moves and improving Mexico performance.
How Auna S.A. Is Heading Toward Its Net Leverage Target

How Auna S.A. Is Heading Toward Its Net Leverage Target

AUNA holds leverage at 3.6X but targets sub-3X, backed by rising free cash flow, refinancing moves and improving Mexico performance.
📰

Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain

MELBOURNE, Australia, March 24, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceutical...
📰

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative,...
TVU Networks Partners with Reuters on Satellite-to-IP Migrat

TVU Networks Partners with Reuters on Satellite-to-IP Migration -- A New Foundation for Live News Distribution

LONDON, March 24, 2026 /PRNewswire/ -- TVU Networks is working in partnership with Reuters on a phased migration from satellite to a cloud-managed,...
ANELLO Photonics and Q-CTRL Announce Strategic Collaboration

ANELLO Photonics and Q-CTRL Announce Strategic Collaboration to Redefine Resilient Navigation for UAVs in GPS-Denied Environments

Partnership combines integrated silicon photonics inertial sensing with quantum magnetic navigation, targeting a $1 billion-a-day-global challenge...
📰

Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
📰

ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi

IRVINE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- via IBN -- ECGI Holdings, Inc. (OTC:ECGI) today announced that it has signed a definitive Share...
AAR awarded $450 million in pallet contracts for U.S. Air Fo

AAR awarded $450 million in pallet contracts for U.S. Air Force

WOOD DALE, Ill., March 23, 2026 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government...
📰

ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi

Agreement would add a 29-state licensed mortgage platform to ECGI as it advances a $10M mortgage tokenization pilot and prepares to open its investor...
📰

Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

Microbot Medical® Strengthens LIBERTY®’s Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
« Prev 1 21 22 23 24 25 41 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms